Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02352948 |
|---|---|
| Brief Title: | A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer (ARCTIC) |
| First Submitted : | January 28, 2015 |
| First Submitted that Met QC Criteria : | January 28, 2015 |
| First Posted : | February 2, 2015 (Estimate) |
| Results First Submitted : | February 7, 2019 |
| Results First Submitted that Met QC Criteria : | March 25, 2019 |
| Results First Posted : | April 16, 2019 |
| Last Update Submitted that Met QC Criteria : | October 3, 2023 |
| Last Update Posted : | October 11, 2023 |